Cowen and Company’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,800
Closed -$460K 87
2024
Q3
$460K Buy
+15,800
New +$460K 0.02% 169